Role of Aducanumab in the Treatment of Alzheimer’s Disease: Challenges and Opportunities
Miguel Vaz,1 Vítor Silva,1 Cristina Monteiro,2 Samuel Silvestre1,3 1CICS-UBI - Health Sciences Research Centre, Faculty of Health Sciences, University of Beira Interior, Covilhã, 6200-506, Portugal; 2UFBI – Pharmacovigilance Unit of Beira Interior, University of Beira Interior, Covilhã, 6200-506, Po...
Main Authors: | Vaz M, Silva V, Monteiro C, Silvestre S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-05-01
|
Series: | Clinical Interventions in Aging |
Subjects: | |
Online Access: | https://www.dovepress.com/role-of-aducanumab-in-the-treatment-of-alzheimers-disease-challenges-a-peer-reviewed-fulltext-article-CIA |
Similar Items
-
Aducanumab: an uprising hope with vague horizons
by: Delara Hazegh Fetratjoo, et al.
Published: (2023-06-01) -
Aducanumab: evidence from clinical trial data and controversies
by: Rajesh R Tampi, et al.
Published: (2021-10-01) -
Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
by: Serena Silvestro, et al.
Published: (2022-02-01) -
Aducanumab—Hope or Disappointment for Alzheimer’s Disease
by: Karolina Wojtunik-Kulesza, et al.
Published: (2023-02-01) -
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
by: Mingchao Shi, et al.
Published: (2022-04-01)